Prognostic stratification of colorectal cancer patients: current perspectives

Nora I Schneider, Cord LangnerInstitute of Pathology, Medical University of Graz, Graz, AustriaAbstract: Tumor staging according to the American Joint Committee on Cancer/Union for International Cancer Control tumor, node, metastasis (TNM) system is currently regarded as the standard for staging of...

Full description

Bibliographic Details
Main Authors: Schneider NI, Langner C
Format: Article
Language:English
Published: Dove Medical Press 2014-07-01
Series:Cancer Management and Research
Online Access:http://www.dovepress.com/prognostic-stratification-of-colorectal-cancer-patients-current-perspe-a17445
id doaj-6e607a58eef4423bbdcdb336dd8b20f8
record_format Article
spelling doaj-6e607a58eef4423bbdcdb336dd8b20f82020-11-25T00:21:56ZengDove Medical PressCancer Management and Research1179-13222014-07-012014default29130017445Prognostic stratification of colorectal cancer patients: current perspectivesSchneider NILangner C Nora I Schneider, Cord LangnerInstitute of Pathology, Medical University of Graz, Graz, AustriaAbstract: Tumor staging according to the American Joint Committee on Cancer/Union for International Cancer Control tumor, node, metastasis (TNM) system is currently regarded as the standard for staging of patients with colorectal cancer. This system provides the strongest prognostic information for patients with early stage disease and those with advanced disease. For patients with intermediate levels of disease, it is less able to predict disease outcome. Therefore, additional prognostic markers are needed to improve the management of affected patients. Ideal markers are readily assessable on hematoxylin and eosin-stained tumor slides, and in this way are easily applicable worldwide. This review summarizes the histological features of colorectal cancer that can be used for prognostic stratification. Specifically, we refer to the different histological variants of colorectal cancer that have been identified, each of these variants carrying distinct prognostic significance. Established markers of adverse outcomes are lymphatic and venous invasion, as well as perineural invasion, but underreporting still occurs in the routine setting. Tumor budding and tumor necrosis are recent advances that may help to identify patients at high risk for recurrence. The prognostic significance of the antitumor inflammatory response has been known for quite a long time, but a lack of standardization prevented its application in routine pathology. However, scales to assess intra- and peritumoral inflammation have recently emerged, and can be expected to strengthen the prognostic significance of the pathology report.Keywords: colorectal cancer, lymphatic invasion, blood-vessel invasion, perineural invasion, tumor budding, tumor necrosishttp://www.dovepress.com/prognostic-stratification-of-colorectal-cancer-patients-current-perspe-a17445
collection DOAJ
language English
format Article
sources DOAJ
author Schneider NI
Langner C
spellingShingle Schneider NI
Langner C
Prognostic stratification of colorectal cancer patients: current perspectives
Cancer Management and Research
author_facet Schneider NI
Langner C
author_sort Schneider NI
title Prognostic stratification of colorectal cancer patients: current perspectives
title_short Prognostic stratification of colorectal cancer patients: current perspectives
title_full Prognostic stratification of colorectal cancer patients: current perspectives
title_fullStr Prognostic stratification of colorectal cancer patients: current perspectives
title_full_unstemmed Prognostic stratification of colorectal cancer patients: current perspectives
title_sort prognostic stratification of colorectal cancer patients: current perspectives
publisher Dove Medical Press
series Cancer Management and Research
issn 1179-1322
publishDate 2014-07-01
description Nora I Schneider, Cord LangnerInstitute of Pathology, Medical University of Graz, Graz, AustriaAbstract: Tumor staging according to the American Joint Committee on Cancer/Union for International Cancer Control tumor, node, metastasis (TNM) system is currently regarded as the standard for staging of patients with colorectal cancer. This system provides the strongest prognostic information for patients with early stage disease and those with advanced disease. For patients with intermediate levels of disease, it is less able to predict disease outcome. Therefore, additional prognostic markers are needed to improve the management of affected patients. Ideal markers are readily assessable on hematoxylin and eosin-stained tumor slides, and in this way are easily applicable worldwide. This review summarizes the histological features of colorectal cancer that can be used for prognostic stratification. Specifically, we refer to the different histological variants of colorectal cancer that have been identified, each of these variants carrying distinct prognostic significance. Established markers of adverse outcomes are lymphatic and venous invasion, as well as perineural invasion, but underreporting still occurs in the routine setting. Tumor budding and tumor necrosis are recent advances that may help to identify patients at high risk for recurrence. The prognostic significance of the antitumor inflammatory response has been known for quite a long time, but a lack of standardization prevented its application in routine pathology. However, scales to assess intra- and peritumoral inflammation have recently emerged, and can be expected to strengthen the prognostic significance of the pathology report.Keywords: colorectal cancer, lymphatic invasion, blood-vessel invasion, perineural invasion, tumor budding, tumor necrosis
url http://www.dovepress.com/prognostic-stratification-of-colorectal-cancer-patients-current-perspe-a17445
work_keys_str_mv AT schneiderni prognosticstratificationofcolorectalcancerpatientscurrentperspectives
AT langnerc prognosticstratificationofcolorectalcancerpatientscurrentperspectives
_version_ 1725360467960922112